Chemical Component Summary

NameSALBUTAMOL
Identifiers4-[(1R)-2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol
FormulaC13 H21 N O3
Molecular Weight239.31
TypeNON-POLYMER
Isomeric SMILESCC(C)(C)NC[C@@H](c1ccc(c(c1)CO)O)O
InChIInChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1
InChIKeyNDAUXUAQIAJITI-LBPRGKRZSA-N

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count1
Bond Count38
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB13139 
NameLevosalbutamol
Groups
  • approved
  • investigational
DescriptionLevosalbutamol, or levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). [Salbutamol] has been marketed as a racemic mixture, although beta2-agonist activity resides almost exclusively in the (R)-enantiomer. The enantioselective disposition of salbutamol and the possibility that (S)-salbutamol has adverse effects have led to the development of an enantiomerically pure (R)-salbutamol formulation known as levosalbutamol (levalbuterol).
Synonyms
  • (-)-Salbutamol
  • Levosalbutamol hydrochloride
  • Levalbuterol
  • Levosalbutamol
  • Levosalbutamol sulfate
Brand Names
  • Levalbuterol Inhalation Solution
  • Xopenex HFA
  • Levalbuterol Hydrochloride
  • Xopenex
  • Levalbuterol Inhalation
IndicationIndicated for the management of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma.
Categories
  • Adrenergic Agonists
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • Agents producing tachycardia
  • Agents that produce hypertension
CAS number34391-04-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Beta-2 adrenergic receptorMGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFG...unknownagonist
Solute carrier organic anion transporter family member 1B1MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...unknownsubstrate
Solute carrier organic anion transporter family member 1B3MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKI...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDBHHPHE
PubChem123600
ChEBICHEBI:8746
ChEMBLCHEMBL1002
PharosCHEMBL1002